Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Protamine Sulfate
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : Action Research Group
Deal Size : Inapplicable
Deal Type : Inapplicable
Antagonization of Heparin with Protamine Sulfate After TAVI
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
January 22, 2024
Lead Product(s) : Protamine Sulfate
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : Action Research Group
Deal Size : Inapplicable
Deal Type : Inapplicable